Number of the records: 1  

Mitochondrial targeting of [alpha]-tocopheryl succinate enhances its pro-apoptotic efficacy: A new paradigm for effective cancer therapy

  1. 1.
    SYSNO0360075
    TitleMitochondrial targeting of [alpha]-tocopheryl succinate enhances its pro-apoptotic efficacy: A new paradigm for effective cancer therapy
    Author(s) Dong, L.-F. (AU)
    Jameson, V.J.A. (NZ)
    Tilly, D. (AU)
    Procházka, L. (CZ)
    Rohlena, Jakub (BTO-N) RID, ORCID
    Vališ, Karel (BTO-N)
    Truksa, Jaroslav (BTO-N) RID, ORCID
    Zobalová, Renata (BTO-N) RID
    Mandavian, E. (US)
    Klučková, Katarína (BTO-N) RID
    Stantic, M. (AU)
    Štursa, Jan (UOCHB-X) [970/97]
    Freeman, R. (AU)
    Witting, P.K. (AU)
    Norberg, E. (SE)
    Goodwin, J. (AU)
    Salvatore, B.A. (US)
    Novotná, Jana (BTO-N) RID
    Turánek, J. (CZ)
    Ledvina, Miroslav (UOCHB-X) [970/97] RID
    Hozák, Pavel (UMG-J) [25] RID, ORCID
    Zhivotovsky, B. (SE)
    Coster, M. (AU)
    Ralph, S.J. (AU)
    Smith, R.A.J. (NZ)
    Neužil, Jiří (BTO-N) RID
    Source Title Free Radical Biology and Medicine. Roč. 50, č. 11 (2011), s. 1546-1555. - : Elsevier
    Document TypeČlánek v odborném periodiku
    Grant GA204/08/0811 GA ČR - Czech Science Foundation (CSF)
    GAP301/10/1937 GA ČR - Czech Science Foundation (CSF)
    IAA500520702 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    KAN200520703 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    KJB500970904 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    KAN200100801 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    CEZAV0Z50520701 - BTO-N (2007-2013)
    AV0Z50520514 - UMG-J (2005-2011)
    AV0Z4055905 - UOCHB-X
    Languageeng
    CountryUS
    Keywords Triphenyl phosphonium * reactive oxygen species * apoptosis
    Permanent Linkhttp://hdl.handle.net/11104/0197713
    FileDownloadSizeCommentaryVersionAccess
    Dong et al., 2011, Free Radic Biol Chem.pdf5444.4 KBPublisher’s postprintrequire
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.